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ABSTRACT
SUPEROXIDE DISMUTASE PROTECTS
CARDIOMYOCYTES DURING HYPEROXIA
Mervat Elsayed Ali
Old Dominion University, 2006
Director: Dr. Frank J. Castora

Reactive oxygen species are implicated in tissue damage in many cardiovascular
diseases. The current study was designed to test the hypothesis that exposure to high
inspired oxygen concentrations (100%) damages cardiac mitochondria and that a
biogenic response is needed for cell survival. The study was done in mice with a
transgene (TG) for extracellular superoxide dismutase (EC-SOD) or with the ECSOD gene knockout (KO). Adult EC-SOD mice and their wild type littermates and
EC-SOD KO mice and their wild type littermates were exposed to 100% oxygen for 6
hours and for 72 hours, and the hearts were subsequently removed under deep
anesthesia. The mortality rate in KO mice after 72 hours (25%) was significantly
higher than wild type littermates (10%) and TG mice (4.2%). In the EC-SOD TG
mice, 6 hours of exposure to hyperoxia activated the transcription of nuclear genes
important for mitochondrial biogenesis- nuclear respiratory factors (NRF-1 and NRF2) and their co-regulator PGC-la -leading to expression of mitochondrial
transcription factor A (Tfam), which regulates mitochondrial transcription and
replication. Hyperoxia also induced activation of NRF-1 and NRF-2 in EC-SOD KO
mice after 6 hours but down-regulated Tfam and PGC-la transcripts. But after 72
hours, mRNA expression for NRF-2, PGC-la and Tfam increased in these mice.
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The protein expression of the pro-survival Protein Kinase B (Akt) was
significantly increased by hyperoxia in the TG hearts after 6 hours (/?<0.05) and
significantly decreased in KO mice (p<0.05). The protection of mitochondrial DNA
(mtDNA) deletion was significantly higher in KO (23%) than in the TG hearts
(3.4%). The transcription of mitochondrial 12S rRNA and nuclear COXIV increased
significantly in TG hearts and decreased significantly in KO hearts (p<0.05). The
pro-apoptosis markers, p-Bad and p-GSK-3(3, which are phosphorylated by Akt,
increased significantly in TG cardiomyocytes and decreased significantly in KO
cardiomyocytes.
In conclusion,

Systemic hyperoxia consistently increases mitochondrial

biogenesis markers in the mouse heart, most prominently in EC-SOD TG mice, and
co-incidentally with increases in Akt, p-Bad and p-GSK-3p. This suggests that
extracellular reactive oxygen products activate mitochondrial biogenesis and the pro
survival pathway in TG mice. Also, hyperoxia decreased the activation of Tfam and
PGC-la transcription after 6 hours and increased it again after 72 hours in KO mice.
This was associated with a decrease in expression of Akt, p-Bad and p-GSK-3P and
an increase in p38, indicating that either hyperoxia activated mitochondrial biogenesis
and pro-survival pathways through p38 or that hyperoxia produced more oxidative
damage to the mitochondria in the KO. In the latter case, the increase in p38 may be a
signal for activation of apoptotic pathways.
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1
CHAPTER I
INTRODUCTION

Oxygen therapy is one of the most frequently used treatments in clinical
medicine. It is administered to decrease and prevent tissue hypoxia in patients with acute
and chronic cardiovascular and pulmonary diseases and also for premature infants with
respiratory distress syndrome. Oxygen therapy is also important for many patients after
heart surgeries such as coronary artery bypass. Ironically, oxygen at sufficiently high
concentrations is toxic to all cells because of its propensity to accept electrons, resulting
in incompletely reduced chemical species known as reactive oxygen species (ROS). The
degree of oxygen toxicity is proportional to the oxygen concentration and the duration of
exposure. Therefore, the administration of oxygen at concentrations higher than 60% at
sea level can be toxic to the lungs, and in the newborn, to the eyes [1]. Pure oxygen
concentrations higher than atmospheric, known as hyperbaric oxygenation, markedly
accelerates oxygen toxicity in many organs including the lungs, the brain, and the heart.
Excessive ROS are scavenged by endogenous antioxidant defenses that protect
the tissues from oxidative damage. The balance between ROS production and antioxidant
capacity is very important, and its disruption contributes to the pathophysiology of
numerous diseases. ROS are proposed to contribute to the deterioration of cardiac
function in patients with heart diseases. It has been reported that ROS are increased in the
failing heart, and are involved in atherosclerosis and myocardial ischemia/perfusion
injury. Antioxidant enzymes are decreased in the decompensated heart, depressing

The journal model for this dissertation is Current Biology.
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the defenses against oxidative stress. Overexpression of antioxidant enzymes, such as the
extracellular isoform of superoxide dismutase (EC-SOD) has been found to protect the
lungs from oxidative damage due to hyperoxia. The effect of increased expression of the
EC-SOD gene or its deficiency in the heart after high level oxygen concentration is
unknown. In this dissertation, I studied the effects of hyperoxia (100% oxygen) exposure
on heart mitochondria in mice and the role of EC-SOD in protection from high oxygen
damage.

Hyperoxia and Production of Reactive Oxygen Species (ROS)
Molecular oxygen is an excellent terminal electron acceptor. In mitochondria, the
high affinity of oxygen for electrons provides a large thermodynamic driving force for
oxidative phosphorylation (OXPHOS). The transfer of four electrons leads to safe
products (two molecules of H2 O), but partial reduction generates hazardous reactive
oxygen species (ROS). The first ROS produced in the univalent reduction pathway of O2
to water is the superoxide anion radical (.O2 "). In particular, superoxide anion, is a
potentially destructive compound formed by the transfer of a single electron to O2 .
O2

+

e —*■

.O2

(1)

In the normoxic environment only 0.1-1.0% of the electrons transferred to O2
result in .O2 " production in most cells, but the production of .O2 " is markedly accentuated
under hyperoxic conditions. Spontaneous or enzymatic [via superoxide dismutase (SOD)]
dismutation of .O2 " produces hydrogen peroxide (H2 O2 ):
,0 2' + .0 2' + 2 H + -» H 20 2 + 0 2
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(2)

Hydrogen peroxide can also be produced directly from O2 via enzymatic bivalent
reduction.

Superoxide can act as either an oxidant or a reductant, but under the

intracellular reducing environment, it functions primarily as an oxidant. For example,
superoxide produced by cellular reductants and autoxidation of respiratory chain electron
carriers inactivates iron-sulfur-containing dehydratases including 6-phosphogluconate
«

dehydratase and the citric acid cycle enzyme aconitase. Oxidation of [4Fe-4S]

9 - 1-

clusters "

in dehydratases such as aconitase inactivates the enzymes by releasing Fe2+ from the
cluster. Reactivation is achieved by iron-sulfur cluster reduction and Fe
9 - 1-

'y

1

insertion.

•

Inactivation-reactivation is a dynamic however Fe , can reduce H2 O2 in a Fenton-type
reaction producing hydroxyl radical (OH'):
.0 2" + Fe3+ -+ 0 2 + Fe2+

(3)

H 2O2 + Fe2+ —» HO' + OH" +Fe3+

(4)

In addition, .O2 ' reacts with nitric oxide (NO’) at a diffusion-limited rate
producing peroxynitrite (ONOO):
0 2" +NO' -» ONOO"
Peroxynitrite is directly toxic to molecules containing sulfhydryl groups. It also can be
protonated to peroxynitrous acid, which spontaneously decomposes to produce an OHlike species and NO2 . HO' and ONOO" are among the most potent oxidants in biological
systems, and they are capable of oxidizing DNA, proteins and lipids leading to tissue
injury [2],
ONOO" + H+

HONOO -> .OH + N 0 2

(5)

Superoxide does not diffuse across biological membranes readily because of its
negative charge. Thus, it is compartmentalized where it is produced. In the cytoplasm,
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O2 " can be generated either non-enzymatically via autoxidation of small molecules such
as thiols, hydroquinones and catecholamines, or enzymatically by various oxidases and
dehydrogenases such as xanthine oxidase and flavoprotein dehydrogenase.
The mitochondrial electron transport chain is a major site of .O2 ' production mainly via
autoxidation of ubisemiquinone. The microsomal electron transport system present in the
endoplasmic reticulum is also a source of .O2 ". In phagocytic cells such as neutrophils and
macrophages, the NADPH oxidase system present in the plasma membrane releases large
amounts of .O2 ’ into the phagosomes and extracellular space when activated. Moreover,
the peroxisomes are an important source of intracellular H2 O2 .
Persistent exposure to high oxygen concentration (hyperoxia) increases the
formation of more reactive oxygen species that induce damage to most of the cellular
organelles.

ROS and Mitochondria
ROS can damage various cellular components such as proteins, lipids, and nucleic
acids [3, 4]. ROS also mediate mtDNA damage, alterations of gene expression, and
mitochondrial dysfunction [5]. Mitochondrial injury is evidenced by mitochondrial DNA
(mtDNA) damage, as well as by a decline in mitochondrial RNA (mtRNA) transcription,
protein synthesis, and general function. MtDNA is located within the matrix space of the
mitochondria in close proximity to the electron transport chain. Due to this location, and
its low repair capabilities, and lack of protective histone-like proteins, mtDNA is
probably more vulnerable to oxidative damage than nuclear DNA [6, 7]. MtDNA deletion
and mutation may prevent its replication and expression. Further, ROS may induce
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progressive destruction of mtDNA, and this type of damage can lead to a decline in
mtRNA transcription as well as a loss of function [8].
The mitochondrial respiratory chain Complexes I and III have been shown to be a
major source of ROS in vitro [9]. ROS production increases in patients with
mitochondrial cardiomyopathy [8] and recent studies have suggested a definite link
between excessive generation of ROS and the development of myocardial remodeling
and damage [5, 10]. Additionally, the amount of ROS generated, as determined by
electron spin resonance spectroscopy, increases in the murine model of myocardial
infarction [10]. Furthermore, mitochondrial electron transport has been shown to be a
possible site for .O2 - generation during heart failure.

Mitochondria Oxidation and Biogenesis
Mitochondria contain a closed, circular, double-stranded DNA of about 16.5 kb and
16.35 kb in human and mouse, respectively. The mitochondrial genome is similar to the
bacterial genome in that both the heavy and light strands are transcribed. The
mitochondrial

genome

encodes

thirteen

polypeptides

phosphorylation, including seven subunits of

involved

in

oxidative

NADH-ubiquinone oxidoreductase

(Complex I) (ND1, ND2, ND3, ND4, ND4L, ND5, and ND6), 1 subunit (cytochrome b)
of ubiquinol-cytochrome c oxidoreductase (Complex III), 3 subunits (COI, COII, and
COIII) of cytochrome c oxidase (Complex IV), and 2 subunits (ATPases 6 and 8) of
Complex V along with 22 tRNA and 2 rRNA (12S and 16S) subunits (Figure 1.1).
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Complex I
Complex III
ComplexlV
Complex V

Figure 1.1. Illustration Map of Mouse Mitochondrial Genome. The 16.35 Kb mouse
mitochondrial genome which includes 13 genes of the OXPHOS system 2 rRNA (12S
and 16S) and 22 tRNA. PH and PL represent the promoters of the heavy and light
strands. The figure also shows the site of the mtDNA deletion primers (mtfl and mtr2)
used for the deletion analysis in the study.

Although mitochondria have their own genetic system, the protein encoding of mtDNA is
limited to only the 13 most hydrophobic subunits of the respiratory apparatus mentioned
above. Thus, mitochondria rely on nuclear genes to provide the majority of proteins and
factors required for OXPHOS. Mitochondrial replication and transcription depend on
nuclear proteins such as DNA polymerase y, RNA polymerase II and mitochondrial
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7
transcription factor A (Tfam). Tfam stimulates the transcription from bidirectional
promoters within the D-loop region, and it is also essential for mtDNA replication.
Regulation of mitochondrial biogenesis largely depends on the expression of
nuclear respiratory factors (NRF-1 and -2). Nuclear peroxisomal proliferator-activated
receptor gamma co-activator a (PGC-la) has been suggested as a master regulator of the
mitochondrial biogenesis and has a major impact on the NRF system. When introduced
into muscle cells it dramatically induces gene expression for NRF-1, NRF-2 and Tfam
[11] (Figurel.2). Furthermore, PGC-la physically interacts with NRF-1 and co-activates
its transcriptional activity. A dominant negative allele of NRF-1 completely blocks the
ability of PGC-la to induce mitochondrial proliferation, indicating the importance of the
association of the transcriptional factor/cofactor pair [12]. Furthermore, mutations that
affect PGC-la expression lead to loss of heart mitochondria and down regulation of
mitochondrial enzyme [13]. Interestingly, PGC-la has also been shown to be induced in
brown fat cells upon cold stimulation, which suggests that PGC-la strongly co-activates
several nuclear receptors (PPAR gamma, PPAR alpha, RAR and TR) that bind to
mitochondrial uncoupling protein-l(UCP-l) enhancer [12]. In the heart PGC-la was
found to activate the gene expression of UCP-2 and UCP-3 after LPS stimulation [14].
In contrast to nuclear-encoded genes, mitochondrial-encoded gene expression is
primarily regulated by mtDNA copy number [15], A recent study in our laboratory [14]
showed that lipopolysaccharide (LPS) administration to rats resulted in mtDNA deletion
in the heart which decreased mtDNA copy number and decreased mtDNA gene
transcription. Defective mtDNA generates more ROS by defective OXPHOS, which
leads to more mitochondrial damage. Recovery of mitochondria after oxidation by LPS
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8
was shown to involve increased mitochondrial transcriptional factor A (Tfam) and DNA
polymerase y expression which are important for mitochondrial biogenesis. The
transcription of other mitochondrial biogenesis markers; PGC-la and the nuclear
respiratory factors (NRF-1 and NRF-2) is also increased after the oxidative stimulation
by LPS (Figure 1.2).

Oxidative stress

NRF-1

NRF-2

NO

GC-1o
NRF-2

Transcription activation of OXPHOS genes and mtTFA

Figure 1.2. Oxidative Stress and Activation of Mitochondrial Biogenesis Markers.
Oxidative stress stimulates transcriptional activation of NRF-1 and NRF-2 and in the
presence of the co-activator PGC-la they activate the transcription of OXPHOX genes
and mitochondrial transcription factor A (mtTFA).
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ROS and Pro-Survivai Pathways
Biogenic factors (cold, exercise, infection and oxidative stress) stimulate the
•

•

2"h

activation of mitochondrial biogenesis. Changes in the intracellular Ca

concentration

and ATP/AMP ratio activate Ca2+/ calmodulin-dependent protein kinase (CAMK), and
protein kinase C (PKC) has been implicated in the regulation of expression of respiratory
genes in the skeletal muscle. Constitutive expression of CAMKIV shows an increase in
the level of PGC-la and increased mitochondrial biogenesis [16].
It is also reported that PGC-la can be activated by a p38 MAPK-sensitive
pathway. MAPK p38 is a stress-activated kinase that responds to extracellular stimuli
such as UV light, heat, osmotic shock, inflammatory cytokines (TNF-alpha and IL-1) and
growth factors [17-20]. Regulation of respiratory gene expression via p38 MAPK
dependent pathways and induction of mitochondrial proliferation by extrinsic factors
such as cytokines has been reported. The involvement of p38 MAPK-dependent
pathways in oxidative stress-induced increase in mitochondrial biogenesis is not well
established.
The pro-survival phosphatidylinositol 3 kinase (PI3K) -Akt pathway has been
shown to activate mitochondrial biogenesis in hepatic rat mitochondria after LPS
stimulation [21]. Akt is also stimulated by growth and survival factors [22]. There are
three isoforms of Akt, known as Aktl (PKBa), Akt2 (PKBJ3), and Akt3 (PKBy). Aktl is
ubiquitously expressed with high expression in heart, brain and lung [23]. All three
isoforms of Akt share three domain structures consisting of an N-terminal pleckstrin
homology (PH) domain, followed by a kinase domain related to protein kinases A and C
( containing Thr

#

#

in Aktl) and a C terminal regulatory domain ( containing Ser
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Aktl). PH domains have high-affinity recoginition of phosphoinositide head groups.
Activation of PI3- kinase leads to phosphorylation of membrane phosphatidylinsitol-(4,
5)-bisphosphate [Ptdlns (4, 5) P2] generating Ptdlns (3, 4, 5) P3. Accumulated Ptdlns
(3,4)P2 and Ptdlns (3,4,5) P3 recruit Akt containing the PH domain to the plasma
membrane [24]. There Akt is phosphorylated at Thr308 and Ser473 [25, 26].
Phosphoinositide-dependent protein kinase-1(PDK1) and integrin-linked kinase (ILK)
phosphorylate Thr 308 Ser473 respectively [27, 28].
Activation of Akt induces activation of downstream pathways important for cell
survival and inhibition of apoptosis. Akt phosphorylates the pro-apoptotic protein Bad, a
member of the Bcl-2 family which promotes cell survival. A second downstream pro
survival and anti-apoptotic mechanism is through phosphorylation of the glycogen
synthase kinase (GSK-3|3). Phosphorylation of GSK-30 leads to inactivation of the
enzyme and reduces apoptosis [29, 30]. In addition, several studies indicate that
activation of PI-3K/Akt suppresses caspase-3 activation and DNA fragmentation in a
variety of cell lines [31-33].

ROS and Apoptosis
ROS function as signal transduction intermediates to induce transcription factor
activation, gene expression, and cell growth; they also can induce apoptosis [34]. When
the capacity of the antioxidant system is compromised, exposure of living tissue to higher
oxidative stress will result in increased levels of defective mitochondria and mutated
mtDNA, and thus create a cycle of increased ROS production and oxidative damage.
When ROS increase above a threshold, mitochondrial damage irreversibly activates cell
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death. Increased ROS leads to conformational changes in the adenine nucleotide
translocator, the voltage gated anion channel protein (porin), the peripheral
benzodiazepine receptor, and cyclophylin that are all involved in a pore complex between
the outer and inner mitochondrial membrane. This protein pore can open to allow
dissipation of the mitochondrial membrane potential and pH gradient. This is referred to
as the mitochondrial permeability transition (MPT), or opening of the mitochondrial
transition pore [35, 36], Excess production of peroxides also oxidizes the glutathione
pool and may also allow the formation of dithiols on the mitochondrial permeability
transition (MPT) pore, which triggers pore opening [37], leads to the release of
cytochrome c (cyt c), apoptosis initiation factor (AIF), and mitochondrial protective
factors from mitochondria.
In the cyotoplasm, cytochrome c interacts with Apaf-1 and caspase 9 to activate
caspase 3. Caspase 3 has a cleavage effect on pre-PARP, ICAD, and pre-Acinus which
together with AIF is also released from the mitochondria. The assembly of an
apoptosome (cytochrome c, caspase 9 and AIF-1) is directed at the nucleus leading to
chromatin cleavage and nuclear condensation [36]. Moreover, increased ROS may induce
the peroxidation of cardiolipin in the mitochondrial inner membrane, which triggers
dissociation of cytochrome c from cardiolipin [38]. The release of cytochrome c can also
be regulated by the effect of translocation of pre-apoptotic proteins (Bax and Bad) from
the cytosol to the mitochondrial membrane in response to increases in ROS production in
cardiomyocytes [39]. Upon translocation to the mitochondria Bax/Bad associates with the
antiapoptotic protein Bcl-2 to form a heterodimer. Activation of caspases and nucleases
leads to mtDNA degradations decreased mitochondrial transmembrane potential,

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

12
uncoupling of electron transport from ATP production, increased cytosolic calcium and
generation of more reactive oxygen species. Bad has been found to be a substrate for the
pro-survival kinase, Akt [36]. Activation of Akt increases phosphorylation of Bad and
prevents its association with Bcl-2 protein and prevents the initiation of apoptosis.
Akt phosphorylates another pro-apoptotic kinase, glycogen synthase kinase-3 P
(GSK-3P). GSK-3P associates with the MPT, and phosphorylation of this enzyme on its
serine residue number 9 results in its inactivation, and decreases

opening of the

mitochondrial MPT pores [40], Activation of Akt/GSK-3p also inhibits caspase
activation and decreases apoptosis (Figure 1.3).

Growth Factors
1

PI3P

AktfPKB

GSK-3|3

Bad

Transcriptional factors
in the nucleus

t Cell survival

Figure 1.3. Illustration Showing the Activation of Akt through PI3P and its Downstream
Pathway. Activation of Akt through PI3P leads to activation of transcription factors in the
nucleus and increase cell survival. In the other hand activation of anti-apoptotic proteins
(Bad and GSK-3P) inhibit apoptosis.
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Antioxidant Systems
Cellular defense against ROS-mediated injury includes both enzymatic and nonenzymatic antioxidant systems. While non-enzymatic antioxidants such as reduced
glutathione (GSH), a-tocopherol (vitamin E), and ascorbic acid (vitamin C) serve
important role in cellular antioxidant defense, the enzymatic antioxidant system plays the
major roles in the cellular defense against oxygen toxicity. The superoxide dismutases,
catalase, and the glutathione peroxidases constitute the major enzymatic antioxidant
systems.

Superoxide Dismutases (SOD)
Superoxide dismutases are the most important class of antioxidant enzymes; they
are metalloenzymes that catalyze the dismutation of two superoxide radicals (.O2 ) into
hydrogen peroxide (H2 O2 ) and oxygen (O2 ) [41]. H2 O2 can be further metabolized to
water by catalase or other peroxidases. In 1969, the first antioxidant enzyme, Cu,Zn
superoxide dismutase (SOD), was identified in the erythrocyte by McCord and Fridovich,
who found it to catalyze the rapid dismutation of superoxide radical to hydrogen peroxide
and oxygen (dissociation constant (Kj) ~ 3 X 109 M'1 s'1) [42]. Three isoforms of SOD
have now been identified in mammals.

The Cu,Zn isoform (SOD1) is the major

intracellular SOD, and is found primarly in the cytosol, but may also appear in the
nucleus, in lysosomes and in the space between the inner and outer mitochondrial
membranes. Manganese SOD (SOD2), found in the mitochondria, has Mn in the active
site. MnSOD plays an important role in protecting mitochondria from superoxide anions
produced as a byproduct of electron transport required for oxidative phosphorylation.
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Extracellular superoxide dismutase (SOD3) is present mainly in the extracellular matrix.
EC-SOD is considered the principal antioxidant enzyme in the extracellular spaces which
protects the extracellular space from oxidant stress. The Cu and Zn containing SOD,
CuZnSOD and EC-SOD, constitutes approximately 85-90% of the total SOD activity in
the mouse tissues, while MnSOD constitutes approximately 10-15% of total SOD
activity.

Molecular and Biological Characters of EC-SOD
The existence of extracellular SOD was suggested in 1980 by Stephan Marklund
[43]. Examination of human serum and cerebrospinal fluid by gel chromatography
revealed that extracellular fluid contains SOD activity that was immunologically distinct
from the intracellular CuZn SOD [44].
The high molecular weight SOD was subsequently purified from human lungs
where it is highly expressed and named extracellular superoxide dismutase (EC-SOD)
[45]. EC-SOD is a hydrophobic glycoprotein with molecular weight of approximately
135 kd with minor species-specific differences. In most species, EC-SOD is a tetramer of
identical 30 kd subunits, although it is occasionally found as a dimer. The tetramer is
comprised of two dimers linked through disulfide bridges [46, 47]. The enzyme contains
one copper and one zinc ion coordinated to the side chain of a histidine residue in the
active site that catalyzes dismutation of the superoxide anion with a rate constant of 109
M'1 s'1. The copper ions are catalytically active in the dismutation reaction. The Zn does
not function in the catalytic cycle, but stabilizes the enzyme during the reaction. As a
copper-containing enzyme, the activity of EC-SOD is regulated by copper availability.
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Free intracellular copper is extremely limited [48], and soluble carrier proteins or “copper
chaperones” are used for copper trafficking to specific copper-containing proteins. The
copper chaperone that delivers copper to EC-SOD and regulates its activity is called
antioxidant-1 protein (Atoxl) [49]. The copper ions appear to function in the dismutation
reaction by undergoing alternate oxidation and reduction as summarized in the following
equations:
SOD-Cu2+ .0 2 -*• Enzyme-Cu+ + 0 2

(5)

SOD-Cu+ + ,0 2' + 2H+ —+ Enzyme- Cu2+ + H20 2

(6)

The net reaction of the above 2 reactions is:
.0 2- + .02 + 2H+

-► H20 2 + 0 2

(7)

Analysis of cDNA isolated from a human placental cDNA library revealed that
EC-SOD contains 240 amino acids including an 18 amino acid signal peptide for
secretion [50]. The remaining 222 amino acids make up the mature protein. The first 95
amino acids showed no sequence homology with other proteins, but a possible Nglycosylation site was identified at Asn-89. 50% sequence homology with other
eukaryotic CuZn SOD’s is present in residues 96-193 of EC-SOD. Amino acids 194-222
are hydrophilic and contain nine positively charged amino acids, which were believed to
contribute to EC-SOD’s affinity to heparin and heparin sulfate (Figurel.4).
The mature human EC-SOD contains six cysteine residues [50], and occurs
naturally in two different forms with evident disulfide bridges [51]. One form is active
(aEC-SOD) and has a free cysteine residue in position 195. The intrasubunit disulfide
bridge formed by Cysl07 and Cysl89 is necessary for the SOD activity [51]. The other
form has a free cysteine residue at position 45 and is inactive (iEC-SOD). EC-SOD is
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Figure 1.4. Schematic Showing the Structure of the EC-SOD Dimer. The N-terminal
amino acid residues and the position of the single iV-linked glycan at Asn89 are indicated.
The putative intrachain disulfide bridge between Cys107 and Cys189 or possible Cys190 is
shown based on the homology to Cu/Zn-SOD. The C-terminal amino acid residues
include the heparin binding domain.

unusually resistant to high temperatures, extreme pH, and high urea concentrations,
although it can be inhibited by a variety of agents including azide and cyanide and
inactivated by diethyldithiocarbamate and hydrogen peroxide.
The C-terminal region is highly rich in basic amino acid residues [50]. This
polybasic region is involved in the binding to heparin/heparan sulfate [52] and type I
collagen [53], and is referred to as the extracellular matrix (ECM)-binding region [53].
The heparin-binding domains of two EC-SOD subunits are linked by a disulfide bond to
form a cluster of 12 positively charged amino acid residues (Figure 1.2) [47]. These
residues provide the basis for the electrostatic interactions with heparin sulfate which
anchors EC-SOD to specific regions of the extracellular matrix and on the cell surface.
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The ECM region is removed proteolytically just before secretion. This produces both
intact and cleaved subunits of EC-SOD. Hence, the enzyme is heterogeneous in its
affinity for heparin three subtypes of EC-SOD exist; type A has no affinity, type B, with
intermediate affinity, and type C, with high affinity for heparin [54]. The heparin-binding
domain has been proposed to act as a nuclear localization signal in culture cells (3T3-L1)
[55], suggesting that the role of EC-SOD is to protect the genome DNA from damage by
reactive oxygen species and /or the transcriptional regulation of redox-sensitive gene
expression [56].
A natural mutation located in the center of the carboxyl-terminal cluster of
positively charged amino acid residues, which defines the heparin-binding domain, has
been described for human EC-SOD where

ArgGly (R213G). The effect of this

polymorphism, which is found in 4% of Swedish, 3% of Australian and 6% of Japanese
people, increases the concentration of EC-SOD in the plasma of homozygous individuals
10 to 30-fold [57, 58]. This increase in EC-SOD blood concentration, which reflects
decreased tissue antioxidant levels, has now been shown to increase the risk of ischemic
heart disease [58].
The genomic structure and chromosomal localization of the EC-SOD gene has
been mapped in humans to chromosome 4q21, and in mouse to chromosome 5. The
human EC-SOD gene consists of three exons and two introns, while the mouse has two
exons separated by a 4 kb intron. The entire human EC-SOD coding region (720-bp) is
located within exon 3 [59].

The promoter regions of human and mouse EC-SOD

apparently lack classical TATA or CCAAT boxes. In humans, the promoter region of the
gene contains various regulatory elements including two potential antioxidant response
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elements (ARE), AP-1 binding sites, xenobiotic response elements, NF-B motifs, and
C/EBPbeta-binding sites [50, 60, 61].

Regulation of EC-SOD Transcription and Protein Expression
The expression of EC-SOD mRNA and protein, unlike, SOD1 and SOD2, is celland tissue-specific and is prominent in heart, lung, blood vessels, placenta, and kidney.
High levels of EC-SOD mRNA and protein are present in alveolar type II cells, proximal
renal tubular cells, lung macrophages, vascular smooth muscle cells, some fibroblast
lines, glial cells, and endothelial cells. Despite detailed promoter analysis that reveals
multiple potential regulatory sequences, as described above, mechanisms regulating this
cell-specific enzyme expression are not yet known.
In vitro studies in skin fibroblasts indicate that heparin and heparan sulfate induce
both EC-SOD mRNA and protein expression. In vascular smooth muscle cells (VSMC)
and lung alveolar type 2 cells, inflammatory cytokines such as TNF-a and IFN-y are a
potent combination for induction of EC-SOD mRNA and protein expression. Angiotensin
II strongly induces EC-SOD activity in mouse aorta and in cultured human smooth
muscle cells [62] through transcriptional activation and stabilization of the mRNA. This
effect is mainly due to activation of ERK (p42/p44 MAP kinases). Exercise training,
which increases production of nitric oxide in mouse vessel endothelial cells, in turn upregulates expression of EC-SOD in adjacent smooth muscle cells [63]. In this study,
nitric oxide exerted its effect through the MAP kinase p38 pathway. This is an example
of the important relationship between EC-SOD and endothelial nitric oxide synthesis.
While certain stimuli induce EC-SOD expression, a variety of growth factors repress EC-
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SOD mRNA expression. These include TGF-(5 in human fibroblasts [64] and PDGF and
FGF in vascular smooth muscle cells [62].
In a recent study, plasma EC-SOD levels were measured in type 2 diabetic
patients and found to be significantly and inversely related to insulin resistance.
Interestingly, the authors concurrently reported that in cultured fibroblasts, the
C/EBPbeta enhancer, prolactin, which regulates genes associated with insulin resistance,
significantly induced EC-SOD transcription and protein expression [65]. Understanding
the complex regulation of EC-SOD will facilitate further studies to define the role of ECSOD in different disease states.

Biological Role of EC-SOD
EC-SOD is the only known antioxidant enzyme that scavenges superoxide
specifically in the extracellular compartment. Superoxide has only a few direct targets,
but it does maintain iron in the reduced state, which is then available to participate in
Fenton chemistry to produce hydroxyl radical, a highly reactive and toxic ROS. In
addition, superoxide reacts rapidly with nitric oxide (Kd ~ 6.7 X 109 M'1 s'1) to deplete
nitric oxide bioactivity and form a strong oxidant, peroxynitrite. EC-SOD limits these
toxic extracellular reactions. Numerous studies utilized EC-SOD transgenic and knock
out mouse models to show its role in protecting or amplifying tissue injury.

EC-SOD and Diseases
Disruption of EC-SOD localization or activity may contribute to increased ROS
and impaired nitric oxide-mediated vasodilation in cardiovascular diseases [66]. EC-SOD
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protects against oxidation of LDL, a major contributor to atherosclerosis, and EC-SOD
activity is reduced in patients with coronary artery disease. In diabetes, glycation of ECSOD is associated with a decrease in heparin affinity and impaired vascular function [64],
Furthermore, in cardiac ischemia/reperfusion, over-expression of EC-SOD in transgenic
mice or treatment with recombinant EC-SOD preserves cardiac function and decreases
infarct size.

A protective effect for EC-SOD has also been reported in

ischemia/reperfusion injury in the brain and kidney. As EC-SOD promotes nitric oxidemediated vasodilation, [67] so it is suggested that antioxidant treatment improves
coronary and peripheral endothelial function in patients with coronary artery disease or
coronary risk factors [68]. Previous studies showed that overexpression of EC-SOD in
new bom mice protected lung development in hyperoxia-exposed newborn mice [69].
Also overexpression of EC-SOD in the airways of the transgenic mice had been shown to
reduce inflammation and attenuates lung toxicity [70].
The effect of hyperoxia exposure on the heart of the transgenic EC-SOD or the
EC-SOD knockout mice has not been studied before. In this study, I investigated the
effect of exposure to 100% oxygen at sea level (hyperoxia) on cardiac mitochondria of
the transgenic and knockout EC-SOD mice and also the effect of hyperoxia on the
activation of mitochondrial biogenesis and cell survival in these mice.

General Hypothesis and Research Objectives
General hypothesis: Extracellular superoxide dismutase (EC-SOD) plays an
important role in scavenging superoxide radicals in the extracellular milieu, and it also
decreases the oxidative damage to the intracellular compartment especially to
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macromolecules such as DNA and RNA. Based on these actions of EC-SOD, I
hypothesized that EC-SOD functions to protect cardiac mitochondria from oxidative
damage after exposure to hyperoxia (100% oxygen), and improves cell survival through
activation of mitochondrial biogenesis. This hypothesis was tested in mice in which
levels of EC-SOD were genetically altered, which allowed me to investigate the research
objectives.

Specific Aims:
1- Study the effect of overexpression and lack of expression of EC-SOD on activation
of cardiac mitochondrial biogenesis after hyperoxia exposure.
2- Study the effect of hyperoxia in inducing damage to mtDNA, and mitochondrial
RNA transcription in genetic altered EC-SOD mice.
3- Test the hypothesis that the overexpression of EC-SOD will protect
cardiomyocytes from apoptosis which leads to cellular death.
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CHAPTER II
MATERIAL AND METHODS

Animal Protocol
The protocol was approved by The Duke University Animal Care and Use Committee.
The study was carried out in two separate groups - the EC-SOD transgenic (TG) group
and their wild type (C57/BL6-C3) control and EC-SOD knockout (KO) and their wild
type (C57/BL6-J) control group. Both male and female mice were equally represented in
each group and they were between the ages of 9-12 months old.

Transgenic mice (TG) used in this study were generated by Oury et al., (1992) [71] using
an expression vector comprised of the human p-actin promoter coupled to a full-length
cDNA encoding for human EC-SOD. This linearized transgene construct was
microinjected into the pronuclei of fertilized single-cell mouse embryos, which were re
implanted into the oviduct of adult female mouse. Offspring were screened for the
presence of the transgene by Southern blot and/or polymerase chain reaction analysis of
DNA. A founder mouse was then bred with B16-C3 (FI) mice.

Knockout mice (KO) were generated by Carlsson et al., (1995) [60]. The mouse EC-SOD
coding region (exon 2) was replaced with the gene encoding the neomycin-resistance
gene by homologous recombination in embryonic stem (ES) cells. The blastocysts were
isolated from C57/BL6-J mice on day 3.5 of pregnancy, and then ES cells were injected
into each blastocoele cavity. The blastocysts were introduced into the uterine horns of
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pesudopregnant (C57/BL6-J X CBA) FI mice. Offspring were screened for the presence
of the EC-SOD null by Southern blot. The null mice were bred with C57BL/6 mice and
homozygous animals were generated (Figure 2.1).
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Figure 2.1. Illustration Map of of EC-SOD Knockout Gene. A, Restriction map of the
native mouse EC-SOD gene and the disruption of the EC-SOD exon with the neomycin
gene. B, Southern Blot analysis, the wild type gene was recognized as a 6.5 kbp
fragment, whereas the EC-SOD knockout gene was recognized as 3.8 kbp fragment [57].

Exposure to Hyperoxia
Mice were randomly assigned and placed in small-animal chambers with an airtight
oxygen flow rate of 10 L/min. The concentration of oxygen in the chambers was
monitored continuously with a Servomex O2 analyzer (model 572, Sybron, Norwood,
Massachusetts, USA) and maintained at > 99%, except for 10 min/day when the cages
were opened to room air during periods of cleaning and general maintenance. The CO2
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concentration was held below 0.1%, the temperature between 25°C and 26°C, and the
humidity was < 40%. The mice were provided ad libitum access to food and water and
frequently observed for signs of discomfort or O2 toxicity. We exposed two groups of
mice for each experiment, one group for 6 hours and the second group for 72 hours. We
chose these two early (6 hours) and late (72 hours) time periods because at 6 hours
significant changes in the expression of mitochondrial biogenesis markers were observed
and 72 hours was the maximum time that oxidative damages after exposure to hyperoxia
were observed (personal communication with Dr. Piantadosi). Control mice were kept in
identical chambers and exposed only to room air.

Harvest the Mouse Heart
After 6 hours and 72 hours exposure the mice were euthanized using Halothane, the
thoracic cage was opened and the hearts were harvested and snap frozen in liquid
nitrogen and stored in -80°C until use. Mice were taken out of the hyperoxia chamber
individually at the time of sacrificing because acute drops in oxygen concentration (100%
to normal air 21%) caused death in mice that had been exposed to O2 for 72 hours.

Total RNA Isolation
All RNA work was done in a specific area designated for RNA extraction and analysis.
All equipment and glassware were cleaned using RNAase ZAP. TRIZOL reagent (Life
Technologies) was used according to the manufacturer’s instructions:
1-The mouse heart was weighed. For each 100 mg of heart tissue 1ml of TRIZOL
Reagent was added on ice.
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2- The heart was homogenized using a Polytron (Power Gen 125, Fisher Scientific). The
Polytron was washed with DEPC water (RNAase free water) before each sample. The
homogenization was carried out for 10 seconds twice with an interval of 15 seconds.
After homogenization, the sample was left for 5 minutes at room temperature for
complete dissociation of nucleoprotein complexes.
3- Two hundred microliters of chloroform per 1 ml of TRIZOL Reagent were added and
the sample was shaken vigorously by hand for 15 seconds followed by incubation at
room temperature for 2-3 minutes.
4-The sample was centrifuged in a cold microcentrifuge at 4°C at 12,000 x g for 15
minutes to separate the homogenate into an aqueous phase and lower red phenol
choloroform phase (RNA is in the aqueous phase). Three hundred microliters of the
aqueous phase was transferred into a clean 1.5 microcentrifuge tube and 500 pi of
isopropyl alcohol was added to each sample. The sample was gently mixed and left at
room temperature for 10-15 minutes to precipitate the RNA.
5-The sample was centrifuged at 12,000 x g at 4°C for 10 minutes. The RNA pellet was
washed with 75% ethanol in DEPC water (1ml ethanol: 1 ml of TRIZOL).
Next, the sample was centrifuged at 7500 x g for 5 minutes at 4°C. The RNA pellet was
left to air dry for 5 minutes and resuspended in 50 pi of DEPC water and incubated at
55°C for 5 minutes to completely dissolve the RNA pellet.
6-The RNA concentration was measured by diluting 3 pi of sample in 147pi of TE buffer
(Tris- EDTA). The RNA concentration was assayed by spectrophotometer at wavelength
260 nm. We also assayed the absorbance at 280 nm (to check for protein contamination
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in the sample). The 260/280 ratio was 1.8-2 in all samples. The RNA concentration was
calculated according to the equation:
RNA concentration = OD value at 260 x 50 (the dilution factor) x 40.

RNA Gel Electrophoresis
The extracted RNA was separated on 1 % agarose gels in IX TEA Buffer in sterile water
to check the yield of the extraction and the integrity of the RNA. Three microliters of
RNA were diluted with 4 pi of DEPC water and 3 pi of RNA loading buffer (Sigma) and
loaded into the gel. The separation was performed at 70 volts using a Bio RAD power
supply (Model 200/2.0).

Mitochondrial and Nuclear mRNA Expression
One microliter of RNA from each sample was reverse transcribed in a total volume of 25
pi using Moloney murine leukemia virus reverse transcriptase (180 units, Promega) in a
reaction buffer containing dNTPs (2 pi), 0.5 pi Oligo dT primers and random primers in
a ratio 3:2 , DTT (2 pi) and ribonuclease inhibitor RNasin (1 pi) (Promega). First, 1 pg of
RNA was brought up to 13.5 pi with sterile water and incubated in a heat block at 70°C
for 5 minutes to remove the secondary structures. Then, the samples were returned to ice
and 11.5 pi of RT mix was added and incubated in the oven at 42°C for 90 minutes. 1 pi
of the cDNA was amplified using PCR with the different oligonucleotide primers as in
(Table 2.1) to measure the expression level of mRNA of PGC-la, NRF-1, NRF-2, Tfam,
12S rRNA, COX IV, MnSOD and GAPDH. The number of PCR cycles was optimized
during the exponential phase of the PCR by titration of visible products on Gel Star-
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stained agarose gels. Quantification of amplified mRNA signal was done by densitometry
normalized to GAPDH mRNA signal density for each sample using image analysis
software (Bio-Rad).

Protein Expression
Preparation of the sample. Protein expression was assayed by Western immunoblot
analysis. Frozen mouse heart tissue was homogenized in Tris phosphate buffer at pH 7.5
with antiproteases in a ratio 1:10 respectively. The phosphate buffer contains 20 mM
Tris, 150 mM NaCl, 1 mM EDTA, ImM EGTA, 1% Triton X-100, 2.5 mM sodium
pyrophosphate, ImM B-glyerophosphate, 1 mM Na3 V0 4 , lpg/ml Leupeptin and ImM
PMSF. The sample was homogenized using Polytron on ice 3 times for 15 seconds each
and cooled on ice for 30 seconds between homogenizations. Next, the sample was
centrifuged in a cold centrifuge (RC-5 Superspeed refrigerated centrifuge, Sorvall) at 4°C
at 10,000 x g for 10 minutes to pellet down the nuclei and cellular debris. The supernatant
was decanted to a new tube. An aliquot was saved for protein assay and the rest of the
sample was mixed directly with an equal volume of (2x) SDS (Laemmli buffer) 125 mM
Tris-HCl, 4 % Sodium Dodcyl Sulfate (SDS), 20% Glycerol, 100 mM Dithiothreitol
(DDT) and 0.02% Bromophenol blue. The sample was then boiled on a heating block at
95°C for 5 minutes to denature the protein.

Protein Assay
Protein concentration by the Bicinchoninic Acid Method. Reagent A which contains
1% Bicinchoninic Acid and Reagent B which contains 4% Cupper Sulfate (CUSO4 5 H2 O)
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Table 2.1. Primer Sequences Used to Amplify Mitochondrial and Nuclear mRNA
Gene Name

MnSOD
Tfam
COX IV
PGCla
NRF-1
NRF-2
12S rRNA
GAPDH

Sequence

Sense:
Antisense:
Sense:
Antisense:
Sense:
Antisense:
Sense
Antisense:
Sense:
Antisense:
Sense:
Antisense:
Sense:
Antisense:
Sense:
Antisense:

5’ GGCCAAGGGAGATGTTACAA 3’
5’ GCTTGATAGCCTCCAGCAAC 3’
5' GGAAGAGCAGATGGCTGAAG 3’
5’ CCCAATGACAACTCCGTCTT 3’
5’ GTCACACGAGACAGATGA 3’
5’ CATCGAAGGGAGTTTACA 3’
5’ AGCCAGCAGTTTGGTTCTTG 3’
5’ CCACTTTGCCTTCCACAAAT 3’
5’ CCACGTTGGATGAGTACACG 3’
5’ CTGAGCCTGGGTCATTTTGT 3’
5’ CCGCTACACCGACTACGATT 3’
5’ ACCTTCATCACCAACCCAAG 3’
5’ GAATTACGGCTCCTGCTCA 3’
5’ GGAGGCAAGCATAAGACTG 3’
5’ TTCACCACCATGGAGAAGGC 3’
5’ GGCATGGACTGTGGTCATGA 3’

All the primers are synthesized using mouse mitochondrial genome from the gene bank
(accession # NC006914) by Invitrogen.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

29
were mixed together to make a working solution in a ratio 49:1. Bovine Serum Albumin
was used to make standard curve from a stock concentration of 1mg/ml. Serial dilution
ofthe standard was made; 5 pg, 20pg, 40pg, 80 pg, and 160 fig. One ml of the working
solution was added to each tube of the standard and the samples and 5 pi of the protein
homogenate was added to each sample tube run in triplicate. 160 pi of distilled water was
added to each sample tube to make the final volume equal to the volume of the standard.
Both the sample and the standard tubes were incubated in a water bath at 60°C for 30
minutes. Then, 3 ml of distilled water was added to each tube to dilute the concentrated
purple color. Next, the OD was measured at wavelength 562 nm (Spectrophotometer,
Hitachi, U-2000). A standard curve was plotted using computer software and actual
protein values of the samples were obtained.

Gel Electrophoresis for the Protein Sample
The samples were separated on 4-20% gradient polyacrylamide, 15 wells minicassette
gels (Invitrogen). 20 pg of the protein sample was loaded on the gel from each diluted
SDS sample. Color protein Marker (Sigma) was used to identify the bands of interest in
each experiment. Electrophoresis Tris glycin (10 mM) running buffer was used and the
samples were separated at 125 Volts and a constant current of 36 Amps for 90 minutes
using a power supply (Bio-Rad).

Transfer Protein Sample to Immobilon Membrane
The protein bands that were separated on the polyacrylamide gels were electro
transferred to an Immobilon membrane with a pore size of 0.045mm (Millpore
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Corporation). The Immobilon membrane was pre-washed in methanol for 2 minutes and
then in transfer buffer for 10 minutes before the transfer. The transfer was done at
constant current (500 Amps) for one-hour using transfer buffer (25 mM Tris base, 192
mM glycine, 20% methanol in distilled water at pH 8.3). After the transfer, the membrane
was blocked in 5 % non-fat dry milk for 30 minutes followed by a wash with Tris
Buffered Saline with Tween 20 (TBS-Tween) (Sigma) three times for 10 minutes each.

Immunoblotting the Immobilon Membrane
1-The membranes were incubated with different primary antibodies (Akt, pAkt, p38, pp38, p-Bad, pGSK-3B, CAMKIV, alpha-actinin and tubulin antibodies) (Table 2.2) in 5%
non-fat dry milk overnight at 4°C on the shaker.
2- The membrane was washed with TBS-Tween buffer (Sigma) for 10 minutes 3 times
and incubated with HRP-labeled secondary antibodies with dilution 1: 2000 in 5 % milk
for one hour at room temperature.
3-The membrane was washed 3X with TBS-Tween to remove unbound secondary
antibody.
4-Enhanced Chemilluminescence Detection Reagents (Amersham) were used to detect
the protein signal. The HRP/hydrogen peroxide present in the secondary antibody
catalyzes the oxidation of luminol in alkaline conditions. After oxidation, the luminol is
in an excited state that then decays to a ground state by emitting light. The light reaches a
peak after 5-20 minutes and decays slowly with a half life of approximately 60 minutes.
Maximum light emission is detected at 428 nm.
5-The membrane was exposed to x-ray film and developed in a Philips x-ray developer.
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Table 2.2. Primary Antibodies used to detect the Level of Protein Expression in the
Mouse Heart in the Study
Antibodies Type of Antibody Dilution

P-P38
P38
pAkt
Akt
p-Bad
P-GSK-3P
a-Actinin
CAMK-IV
P-Tubulin

Polyclonal
Polyclonal
Polyclonal
Polyclonal
Polyclonal
Polyclonal
Monoclonal
Monoclonal
Monoclonal

1:800
1:1000
1:1000
1:1000
1:1000
1:1000
1:1000
1:800
1:1000

Size of the band

38 KD
38 KD
60 KD
60 KD
45 KD
30 KD
100 KD
59 KD
45 KD

Cataloge#

Source

sc-17852
sc-535
sc-16646
sc-8312
5284
sc-9166
sc-17829
sc-1545
T-4026

Santa Cruz
Santa Cruz
Santa Cruz
Santa Cruz
Cell Signaling
Santa Cruz
Santa Cruz
Santa Cruz
Sigma

Phosphorylated (p) and total primary antibodies were used to detect the expression level
of the activated (phosphorylated) protein and the level of the total protein.
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Mitochondrial DNA Deletion
MtDNA was analyzed for a deletion between direct repeats (direct repeat 16
corresponding to bp 1095 - 4905 of mouse mtDNA) (Figure 2.2) by polymerase chain
reaction (PCR) using mouse mtDNA deletion primers as shown below in Table 2.3 [72]
and Takara Ex Taq Kit ( Takara BIO INC.). The total DNA was extracted by Gen Elute
Mammalian Genomic DNA kit (Sigma), as follows:
1-Frozen heart tissue from mice exposed to hyperoxia and non-exposed (air) mice were
allowed to thaw on ice and then minced into small pieces to enable more efficient lysis.
2-180 pi of STL Buffer was added to about 50 mg of heart tissue. Twenty microliter of
proteinase K (5%) was added and the samples were mixed by vortexing and incubated at
55°C for 4 hours until the tissues were completely digested.
3- After complete digestion 200 pi of SL Buffer was added to the samples and vortexed
thoroughly for 15 seconds followed by incubation at 70°C for 10 minutes.
4- Two hundred micoliters of ethanol (95-100%) was added to the sample, and mixed
thoroughly by vortexing for 5-10 seconds. The contents of the tube were transferred into
a pre-assembled binding column.
5-The sample was centrifuged at 6500 x g for 1 minute. The collection tube was
discarded and 500 pi of lx SW Buffer was added to the binding column to wash and
centrifuged at 6500 x g for 1 minute. Afterwards, the collection was discarded. The wash
step was repeated with centrifugation for 3 minutes at maximum speed (12,000-16,000 x
g) to dry the binding column and to be sure it was free of ethanol.
6- Two hundred microliters of SE Buffer was pipetted into the center of the binding
column and incubated for 5 minutes and then centrifuged for 1 minute at 6500 x g to
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elute the DNA. The eluted DNA was stored at 4°C and used for detection of mtDNA
deletion in the WT, TG, and KO mouse hearts.
7- The DNA sample was amplified using the SQPCR and the mtDNA deletion primers.
The PCR conditions were: first cycle 96 °C for 2 minutes, second cycle 96 °C for 50
seconds, annealing at 50 °C for 40 seconds and extension at 72 °C for 1 minute for 40
cycles with final extention at 72 °C for 6 minutes. The number of PCR cycles was
optimized during the exponential phase of the PCR by titration of visible products on Gel
Star-stained agarose gels.

W ild ty p e
mtDNA

3810-bp

D eletion ty p

mtDNA

_

859-bp
S’ agtcgtaacaaggtaagcat3’

S’ atttctactccttttageat3’

Figure 2.2. Illustration of mtDNA Deletion Primers. The expected mtDNA deletion
occurs between two 16-bp direct repeat sequences 5' act aac cct age cct a 3' (1095-1110)
and 5' tac cct aac cct acc g 3' (4890-4905). The 16-bp direct repeats are represented by
boxes labeled (a and b). Primers 1 and 2 amplify the 859-bp fragment in the presence of
the 3810-bp deletion in the mtDNA. The genes in this region include ND1, ND2, COX1,
16S rRNA and tRNA for six amino acids.
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Table 2.3. Mouse Mitochondrial DNA Deletion Primers Sequences
Primer
mtfl
mtr2

Nucleotide Position
982-1001 bp
5632-5651 bp

Sequence
AGTCGTAAGGTAAGCAT
ATTTCTACTCCTTTTAGCAT

Mitochondrial DNA forward primer (mtfl) and reverse primer (mtrl) designed to detect
deletion in mouse heart mitochondrial DNA.
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EC-SOD Activity Assay
EC-SOD activity was measured by inhibition of cytochrome c reduction as described by
Crapo (1978) [73]. Four heart tissues from control and transgenic mice in air and after 72
hours exposure to hyperoxia (100% oxygen) were weighed and homogenized in 10
volumes of ice-cold 50 mM potassium phosphate buffer (pH 7.4) with 0.3 M KBr, and a
set of antiproteolytic agents (0.5 mM phenyl methylsulfonyl fluoride, 3 mM
diethylentriaminepentaacetic acid, 90 mg of aprotinin per liter, 10 mg of pepstatin per
liter, 10 mg of chymostatin per liter, and 10 mg of leupeptin per liter). The homogenate
was then sonicated, and separation of EC-SOD from CuZn-SOD and Mn-SOD was
accomplished by passage over a concanavalin A-Sepharose column as described
previously [74]. The EC-SOD activity was measured by inhibition of cytochrome c
reduction at pH 10. One unit of SOD activity is defined as the enzyme activity needed to
inhibit a 50% reduction in cytochrome c.

Statistical Analysis
Grouped data were expressed as mean ± SD. Group sizes were n= 4 or 5 for all studies.
Statistics were performed using two-way ANOVA (analysis of variance) followed by
Tukey’s post hoc comparison using Sigma Plot computer software. A p value of 0.05 or
less was accepted as significant.
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CHAPTER III
RESULTS

Because the EC-SOD TG was developed in a strain (C57/B16-C3) different than the one
used for EC-SOD KO (C57/B16-J), we used two different wildtype strains that match
with the respective mouse strain as reference controls. The results from the transgenic
and the knockout mice are separated in the following two parts. The difference of
mitochondrial and nuclear gene expression between each animal group and its control at
the base line (air) was summarized in Table 3.1. Also, the effect of hyperoxia for 6 hours
and 72 hours on the expression of mitochondrial and nuclear genes in the EC-TG and KO
mice is summarized in (Table 3.2 and Table 3.3).

Part I: Effect of Hyperoxia in EC-SOD Overexpressing Mice (TG)
Hyperoxia and Mortality
On exposure to 100% oxygen: after 24 hours the mice started to huddle together and
there were no signs of respiratory distress but prolonged exposure for 72 hours was lethal
to some mice. Hyperoxia was lethal to 12.5% of the exposed WT mice (3/24), while the
mortality rate was lower in the TG mice 4.2% of the exposed mice (1/24), Table 3.4.

Effect o f Hyperoxia on Cardiac mtDNA
Hyperoxia increases reactive oxygen species (ROS), which can be deleterious to
macromolecules such as DNA and RNA. Because mtDNA is sensitive to damage by
ROS, the integrity of mtDNA was assessed by semiquantitatve PCR to detect deletion of
a specific GC-rich region vulnerable to oxidation [72]. The PCR product of the intact
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wild type (WT) mtDNA is 4669 bp, while the size of the deletion between direct repeats
is 3810-bp, producing a PCR product of 859 bp. This deletion was detectable in both WT
and EC-SOD transgenic (TG) mice after oxygen exposure for 72 hours but it was absent
in their littermate air-control mice (Figure 3.1). The amount of deletion was higher in the
WT (4.8%) group than the TG mice (3.4%) but the difference was not statistically
significant.

Hyperoxia and Mitochondrial RNA Transcription
To further evaluate the damage to mtDNA after hyperoxia, the efficiency of
mitochondrial gene transcription was measured using RT-PCR. The level of expression
of 12S rRNA was not different between WT and TG mice at room air (Figure 3.2).
However after 72 hours there was significant decrease in the expression in the WT than
in the TG mice (p<0.05). However, 72 hours of hyperoxia induced a significant decrease
in 12S rRNA expression in the WT compared to their littermate air-control mice
(p<0.05).

Hyperoxia and Nuclear Gene Transcription
To investigate the possibility that hyperoxia induced oxidative damage to the nuclear
genome essential for mitochondrial function, the expression level of COX IV mRNA was
measured. COX IV is a mitochondrial ETC (OXPHOX) subunit protein of Complex IV
encoded by the nuclear genome. At baseline the cardiac transcripts of COX IV were
significantly higher in WT than TG control mice (p<0.05). After hyperoxia the WT
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COX IV mRNA level did not change significantly but COX IV mRNA level in TG heart
increased significantly (about 40%, /?<0.05) (Figure 3.3). This result indicates that
oxidative stress in EC-SOD TG mice might up-regulate transcription of nuclear genes
essential for mitochondrial respiration.

Effect o f Hyperoxia on Cardiac SOD Activity
Total SOD activity was significantly higher in heart homogenate in TG compared to WT
mice (Figure 3.4A) and was mainly due to increases in the EC-SOD isoenzyme, which
was about 2-fold higher (Figure 3.4B). Exposure to hyperoxia decreased WT EC-SOD
activity in WT mice but did not affect the enzyme activity of the TG animals (Figure
3.4B).

Hyperoxia and Mitochondrial Defenses Against Oxidative Stress
MnSOD mRNA Expression.
Since mitochondria are a major source of ROS and free radicals during the exposure to
hyperoxia, we sought to determine whether cardiac cells had responded to the oxidative
stress by inducing the expression of mitochondrial SOD antioxidant enzyme (MnSOD)
(SOD2). We assayed the expression of Mn SOD mRNA, which at baseline (in air) was
already significantly higher in TG mice than in WT mice. Upon stimulation with 100%
O2 both WT and TG mice showed a significant increase in MnSOD level. With
prolonged stimulation for 72 hours the expression of MnSOD dropped in both WT and
TG but the decrease was more in WT (~ 2.6- fold) than in TG mice (~1.6- fold) (Figure
3.5).
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Figure 3.1. Identification of mtDNA Deletion in TG Mouse Hearts. SQPCR amplification
from heart mtDNA of wildtype (WT) and EC-SOD transgene (TG) mice exposed to air
and hyperoxia (100% oxygen) for 72 hours. The upper band (4669 bp) represents the
normal mtDNA that amplified by the deletion primers. The lower band (859 bp)
represents deletion of 3810 bp of mtDNA that was amplified. The deletion was detected
more in WT (4.8%) than the TG (3.4%) mice after exposure to hyperoxia but the
difference was not statistically significant.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

40

JEG.

W L

Air(Oh)

72h

Air(0h)

72h

12S RNA

GAPDH

IE c

lu

t: o
CO w C 8

?

<17

0

Q . C.6
C .4

07
oc

f 9

Air

72h

Time (hours)

Figure 3.2. Mitochondrial Expression of 12S rRNA Transcripts in WT and TG Mouse
Hearts. Top: 2% agarose gels of RT-PCR. Total RNA was prepared from mice hearts in
air and after exposure to 100% oxygen for 72 hours. The RNA was reverse transcribed
with gene specific oligonucleotide primers for mouse mitochondrial 12S rRNA. GAPDH
mRNA was used as a control for RNA loading and efficiency of RT-PCR. Bottom:
Densitometry values showing the relative expression of 12S rRNA expressed as mean
±SEM in air (0 h) and after 72 h exposure to hyperoxia (n = 4 per group*p<0.05).
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Figure 3.3. Nuclear Expression of COX IV mRNA in WT and TG Mouse Hearts.
Top: 2% agarose gels demonstrating RT-PCR products of nuclear COX IV transcripts
in WT and TG hearts in air (0 h) and after exposure to 100% oxygen for 72 hours.
Total RNA was reverse transcribed with gene specific oligonucleotide primers for
mouse nuclear COX IV. Bottom. Histogram shows the densitometry of COX IV
mRNA expression normalized to GAPDH from a representative experiment.
Values are expressed as means ± SD of 4 animals/group (*p<0.05).
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Figure 3.4. SOD activity in wildtype and transgenic mouse hearts. (A) The activity of
EC-SOD in both wild type (WT) and in transgenic mice (TG). (B) The activity of Total
EC-SOD in wildtype and transgenic mice (B). The activity was measured by inhibition of
cytochrome c oxidase reduction at pH 10 in air and after 72 hours exposure to hyperoxia
(100% O2 ) in 4 mouse hearts pooled /group. One unit of SOD activity is defined as the
enzyme activity needed to inhibit a 50% reduction in cytochrome c oxidase.
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Figure 3.5. Expression of Mitochondrial SOD (SOD2) mRNA in WT and TG Hearts.
Top: 2% agarose gel electrophoresis using specific oligonucleotide primers for SOD2
mRNA in EC-SOD TG mice in air and after 6 and 72 hours exposure to 100% oxygen.
Bottom: Histogram shows densitometry of the optical density of SOD2 mRNA
expression normalized to GAPDH mRNA. Values are expressed as means ± SD of 4
animals/group (*p<0.05).
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Effect o f Hyperoxia on Mitochondrial Biogenesis Markers
To test the effect of hyperoxia exposure on stimulating mitochondrial biogenesis, the
transcription of nuclear respiratory factors NRF-land NRF-2 and their transcriptional co
activator (PGC-la) was measured. Nuclear respiratory factors are encoded in the nucleus
and control synthesis of ETC components as well as the transcription of mitochondrial
transcription factor A (Tfam) which regulates transcription and replication of the
mitochondrial genome.

NRF-1 mRNA expression
The expression level of NRF-1 mRNA was measured using RT-PCR. The message was
normalized to the nuclear encoded gene GAPDH. The expression of NRF-1 in air-control
mice between WT and TG groups was similar. On exposure to oxygen for 6 hours, both
WT and TG mice showed an increase in NRF-1 but the expression was most significant
in TG mice (79%, ~ 1.8-fold, p<0.05). With prolonged O2 stimulation for 72 hours the
expression level in TG mice remained elevated, while in WT mice it decreased by 64%
compared to air- control (Figure 3.6A).

NRF-2 mRNA expression
The relative mRNA expression for NRF-2 in air-control groups was about two-fold
higher in TG mice than in WT animals. After 6 hours of exposure to hyperoxia the
expression increased by 80% in WT but in TG mice the increase in mRNA was not
statistically significant. However after 72 hours of exposure the expression was
significantly increased in TG mice by 64% (~ 1.64-fold) compared to the WT mice and
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this difference in NRF-1 expression between the TG and the WT groups was highly
significant (p<0.05). This result showed that the TG mice have a higher basal level of
NRF-2 expression than the WT and the cardiac expression of NRF-2 can be highly
stimulated in the TG mice by O2 exposure (Figure 3.6B).

Tfam mRNA expression
Because Tfam plays an important role in regulating mitochondrial replication and
transcription, the level of Tfam transcripts was measured. The expression of Tfam mRNA
in TG mice in air (normal oxygen) was significantly increased by 20% compared with the
WT group. On stimulation with 100% oxygen for 6 hours the mRNA expression in both
WT and TG mice decreased but only the decline in TG mice (by 61%) was significant.
With prolonged O2 stimulation for 72 hours the Tfam expression in TG mice increased
back to normal levels, (Figure3.6C). The persistent decrease in Tfam expression in WT
mice indicates that oxidative stress was more pronounced in the WT mice than the TG
mice and that oxidative stress affects nuclear genes essential for mitochondrial
biogenesis.

PGC-1 alpha mRNA expression
Because PGC-1 a is a master regulator of mitochondrial biogenesis through co-activation
of nuclear transcription factors (NRF-1 and 2), we wanted to know if the increase in
expression of NRF-1 and NRF-2 after exposure to hyperoxia was associated with an
increase in expression of PGC-la. The expression of PGC-la mRNA increased by -1.8fold (78%) in WT and - 2-fold in TG mice after O2 exposure for 6 hours compared with
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air-control group (p<0.05). With prolonged hyperoxia exposure for 72 hours, PGC-la
mRNA expression was increased by 60% in TG mice but decreased dramatically in WT ~
2.6-fold (Figure3.6D). The increased transcription of PGC-la with coordinate expression
of the downstream genes, NRF-1 and NRF-2, is consistent with the role PGC-1 a as an
important nuclear regulator of respiratory gene expression.

Effect of Hyperoxia on Mitochondrial Biogenesis and Cell Survival
Akt protein expression
Because PGC-la expression was up regulated in EC-SOD- TG mice after hyperoxia, as
was expression of NRF-1 and NRF-2, we were interested in finding the signal that could
induce the expression of NRF-1, NRF-2 and PGC-1 a. Because the murine NRF-1
peptide sequence has an Akt phosphorylation motif (RXRXX (S/T) at position 104-109,
we assessed Akt activation by immunoblot analysis using anti-Akt and anti-phospho-AkT
antibodies. For animals exposed to normal air, the expression level of a 60 KD protein
band of pAkt in TG mice was -1.46 fold (p<0.05) higher than WT mice. After 6 hours of
hyperoxia, p-Akt expression was increased in both WT and TG, but the expression was
marginally increased in TG than the WT. After 72 hours, both WT and TG Akt level
dropped below air-control levels but the level in TG mice was still higher than in WT
(Figure 3.7). These results showed that Akt was activated early after oxidative stress in
the mouse heart and may be the activator for transcription ofNRF-1 after hyperoxia
exposure.
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Figure 3.6. Nuclear Markers for Mitochondrial Biogenesis in WT and TG Mouse Hearts.
The histogram shows the relative mRNA expression of mitochondrial biogenesis
markers; nuclear respiratory factors (NRF-1 and NRF-2 (A&B)), mitochondrial master
regulator PGC-la (C) and mitochondrial transcription factor A, Tfam in (D), in WT and
EC-SOD TG mice hearts. The mice groups were exposed to room air (0 h) and after 6
and 72 hours to 100% oxygen. The densitometry values normalized to GAPDH mRNA
expression. Values are expressed as means ± SD of 4 animals/group (*/K0.05).
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MAPKp38 protein expression
The activation of p38 by cytokines has been reported to activate PGC-la [75].Therefore
we were interested to determine the effect of hyperoxia on p38 in TG mouse heart. The
activation of p38 was measured by Western blot using antibodies to phosphoiylated-p38
(p-p38). The p-p38 expression was normalized to total p38. At baseline p-p38 protein
expression was significantly higher in TG hearts than in WT mice (100%). After 6 hours
of exposure to 100% oxygen, WT mice showed a 2.5 fold increase in p-p38 expression
but the TG mice showed no significant change. With prolonged O2 stimulation, the p-p38
expression level dropped by 50% in TG and WT hearts (Figure 3.8). This result showed
that cardiac p38 was not activated in TG mice heart by stress with hyperoxia. In contrast,
the WT mice had higher p38 activation after 6 hours, suggesting that the cells could be
more likely to undergo apoptosis after prolonged oxygen exposures.

CAMKIV expression
Because Ca2+/calmodulin kinase (CAMK) is known to increase expression of the
respiratory genes and PGC-la and therefore mitochondrial biogenesis, we investigated
the effect of exposure to hyperoxia on the activation of CAMK in TG mice
cardiomyocytes. The protein expression of CAMKIV was assessed by Western blot
analysis. We found that expression of cardiac CAMKIV was significantly higher in TG
mice hearts than in WT in the basal line (air control) and after short term and long term
exposure to hyperoxia (p<0.05) (Figure 3.9).
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Figure 3.7. Western Blot Analysis of Cardiac p-Akt in TG and WT Mouse Hearts.
Western blot were performed using 20 pg of total heart cellular protein of TG (top) and
WT (bottom) and antibody to p-Akt. Total Akt antibody was used as internal control. The
protein expression was measured in air (0 h), after 6 hours, and after 72 hours exposure to
hyperoxia (100% O2 ). Histogram shows densitometry values for p-Akt/Akt as means ±
SD of 5 animals/group (*p<0.05).
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Figure 3.8: Western Blot Analysis of Cardiac p38 in TG and WT. Top, immunoblot
shows protein expression of phosphorylated p38 in EC-SOD TG and WT mice hearts in
air (Oh), and after 6h and 72h exposure to 100% oxygen using specific p-p38 antibody.
Phosphorylated-p38 was normalized to the expression of total p3S.Bottom. Histogram
showing densitometry data expressed as mean ± SED of 3 animal/group (*p<0.05).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

51

Air (Oh)

6h

72h

CAMKIV_»

KO

T u b u lin _ ^
CAMKIV—►

B6

Tubulin

Q. 0.4

2 LU
<
O
Air

Sh

72h

Time (hours)

Figure 3.9. Western Blot Analysis of Cardiac CAMKIV Expression in TG and WT
Mouse Hearts. Top, Immunoblot shows protein expression of cardiac CAMKIV in ECSOD TG and WT mouse hearts in air (0 h), after 6 h and after 72 h exposure to
hyperoxia. The expression level was normalized to tubulin protein expression. Bottom,
Densitometry data was expressed as mean ± SD of 5 animals/group (*p<0.05).
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Effect of Hyperoxia on Cardiac Muscle Survival
Alpha actinin (a-actinin) is the major structural components of sarcomeric Z-lines of
striated muscle. To define if the damage by oxidative stress affects cardiac muscle
integrity, a-actinin protein expression was measured by Western blot. Expression of a
100 KDa band was detected and analyzed by densitometry and normalized to tubulin
protein. The a-actinin expression was higher in TG cardiac mice in air control compared
with the wild type mice. After 72 hours exposure to 100% O2 , a-actinin expression
increased in both TG and WT cardiac muscle and the increase was significant in both
groups (/?<0.05) (Figure 3.10).

p-Badprotein expression.
We investigated whether Bad protein is activated after exposure to hyperoxia. The
expression of 45 KDa phospho-Bad (p-Bad) was assayed by Western blot. The
expression level was analyzed by densitometry and normalized to tubulin protein. The
expression of p-Bad in TG hearts in air-control mice was significantly higher than in WT
air-control mice. After oxygen exposure for 72 hours, cardiac p-Bad expression increased
by 8-fold in WT mice, but only by 1.3 fold in TG mice compared to the air-control group
(Figure 3.11). This result showed that EC-SOD TG mouse hearts have a high continuous
expression of p-Bad at the baseline and that it responds to stimulation by oxygen. This
could explain why these mice are better protected than WT mice from oxidative stress
that leads to apoptosis.
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p-GSK-3p protein expression
We found no significant difference in the expression of p-GSK-3p between TG mice in
air-control and after exposure to hyperoxia. However, WT mice showed a 3.7 fold
increase in p-GSK-3p expression after exposure to hyperoxia. The expression was also
highly significant between the WT and TG mice after hyperoixa (p<0.05) (Figure 3.12).

Part 2: Effect of Hyperoxia in EC-SOD Knockout Mice (KO)
The EC-SOD KO mice were bred on a C57/BL6-J background strain. Therefore the wild
type C57/BL6-J strain was used as control group for the KO mice experiments. EC-SOD
KO mice are phenotypically the same as the wild type mice and they lived to the same
age as the wild type mice (-18 months). On exposure to hyperoxia (100% oxygen ), they
behaved differently: after 24 hours the mice started to huddle together, and after 48 hours
developed signs of respiratory distress, and some died during the exposure.

Hyperoxia and mortality
Hyperoxia was lethal to 10% of the exposed WT mice (2/20), and was more
lethal to the exposed KO mice (6/24, 25%). The mortality occurred between 48 and 72
hours of exposure, Table 3.4. Exposure to 100% oxygen increases formation of reactive
oxygen species which may cause oxidative damage to the organs. The lung and heart are
especially sensitive and may progress to cardiac and pulmonary failure.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

54

WT

TG

100%0272h

Air
i

i

1

Air

00%0272h

r

aA c tin in
T ubulin

1.0

-

1 1 08
CL w
c <0 0.6

.E Qicou j 0 4

Air

72h

Time (hours)

Figure 3.10. Alpha-Actinin Protein Expression in TG Mouse Hearts, a-actinin is a marker
for cardiac muscle integrity. Expression of a-actinin in EC-SOD TG and WT mouse
hearts was measured by Western blot analysis using specific a-actinin antibody. The
relative expression of a-actinin was normalized to tubulin protein expression. The
histogram shows the densitometry data of a-actinin /tubulin expressed as mean ± SD of 5
animals/group (*p<0.05).
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Figure 3.11. Protein Expression of p-Bad in TG Mouse Flearts. Bad is a marker for
apoptosis, protein expression for phosphorylated Bad (p-Bad) in EC-SOD TG and WT
mouse hearts was measured by Western blot analysis using p-Bad antibody. The
expression was measured in basal line (air), and after 72 h exposure to hyperoxia. The
protein expression was normalized to tubulin expression. Densitometry data of pBad/tubulin was expressed as mean ± SD of 5 animals/group (*/?<0.05).
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Figure 3.12. Protein Expression p-GSK-3P in TG Mouse Hearts. Glycogen synthase
kinase-3p (GSK-3P) is a pro-apoptotic protein. Expression of p-GSK-3p in EC-SOD TG
and WT mouse hearts was measured by Western blot using p-GSK- 3p antibody. The
expression was measured in air and after 72 hours exposure to hyperoxia. P-GSK-3P
protein expression was normalized to tubulin protein expression. Densitometry data of pGSK-3p/tubulin was expressed as mean ± SD of 5 animals/group (*/><0.05).
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CHAPTER IV
DISCUSSION AND CONCLUSION

The discussion is divided into three parts: Part 1 discusses and interprets the studies on
EC-TG mice; Part 2 does the same for the EC-SOD KO mice data; Part 3 is a general
discussion and integration of both the TG and the KO mouse data sets. Both sets of
experiments used hyperoxia (100% O2 by inhalation) at early and late (6 and 72 h) time
points. There were, however, initial differences between the two strains of geneticallyaltered mice relative to the appropriate wild type strains that resulted in some important
differences in baseline cardiac gene expression. These differences had never been
characterized previously and probably contributed to the observed strain differences in
survival in hyperoxia (see again Table 3.1).

Part 1: Discussion for EC-SOD TG Mice Data
This study demonstrated for the first time that prolonged exposure to 100% O2 by
inhalation causes changes in gene expression that indicate mitochondrial oxidative stress.
Most notable was the presence of a small amount of 3810 bp deletion in the mtDNA of
the mouse heart. The amount of deleted cardiac mtDNA (3.4%) in the TG mouse was less
prominent than that in WT hearts (4.8%). This oxidant- sensitive mtDNA deletion has
been reported earlier in the rat liver and heart after exposure to LPS and hemin [21, 72,
76]. The large deletion (3810 bp) in the mitochondrial genome includes codons for
NADH dehydrogenase (ND1 and ND2), cytochrome c oxidase (COX I), 16S rRNA and
six tRNAs for amino acids. Mitochondria carrying this deletion in sufficient copy number
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would have both impaired entry of reducing equivalents into the respiratory chain at
Complex I and alterations in the capacity to reduce O2 at Complex IV. This deletion is
mostly accompanied by the accumulation of substantial 8-hydroxyguanine [72] initiated
by oxidation of DNA bases by f^Oi-catalyzed hydroxylation and other strong oxidants
[77-79]. Because mitochondrial DNA is a naked double-stranded circular DNA molecule
and because of its low proofreading efficiency and insufficient repair during replication,
it is vulnerable to oxidative damage and mutations [80].
Overexpression of an extra copy of EC-SOD in TG mice increased the activity of
EC-SOD in TG mice hearts by 2-fold (Figure3.4) over WT. Moreover, the primary
antioxidant enzyme in mitochondria, SOD2 was also increased «2 fold in TG mice
compared to the WT mice after hyperoxia exposure. The reason for the SOD2 response is
unclear and is unexpected. However, the increase in SOD2 and SOD3 activity in the TG
mice provide an explanation for the attenuated damage to the mitochondria after
hyperoxia exposure compared to WT mice. Thus, the link between extracellular and
mitochondrial defensive mechanisms could be directly involved in the protection of cells
and organelles from oxidative damage. The increase in EC-SOD and MnSOD expression
in TG are most responsible for elimination of hyperoxia induced ROS production and
decreased formation of superoxide and peroxynitrite anion (ONOO’).
The significant decrease (29%) in mitochondrial expression of 12S rRNA in WT
hearts after hyperoxia compared to TG mice suggests that either mtDNA in TG mice is
relatively undamaged compared with WT hearts and /or the transcriptional machinery or
the transcriptosome in the TG cardiac mitochondria is not affected by exposure to
hyperoxia. Because Tfam is an essential component of the mitochondrial transcriptosome
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as well as necessary for mtDNA replication and genome maintenance, we investigated
cardiac mRNA expression levels for Tfam before and after oxygen exposure. Tfam
mRNA expression was significantly increased in TG hearts with long term exposure by
1.6-fold but decreased in WT hearts, which is consistent with the decrease in 12S rRNA
expression. This finding supports the notion that low Tfam levels stimulate mtDNA
replication while higher levels stimulate transcription [81]. In addition, these data provide
significant evidence that increases in the extracellular antioxidant EC-SOD can influence
mitochondrial function and biogenesis in response to direct oxidative insults such as
hyperoxia. The increase in the nuclear expression of cytochrome c oxidase (COX IV)
mRNA after exposure to hyperoxia in TG hearts by 40% with no change in WT indicates
that the nucleus in the TG mice has responded positively to the oxidative damage that
targets the mitochondria. Additionally, an earlier study showed that COX IV expression
in cardiomyocytes of WT mice is an early event that peaked by 6 hours and goes down
to 40- 50% by 72 hours (Suliman, unpublished data). This data may explain the blunted
response of COX IV expression in WT hearts after 72 hours of hyperoxia.
The recovery of mitochondrial damage by biogenesis requires coordinated
activation of transcription factors and binding to promoter consensus sequences in
nuclear genes encoding for mitochondrial proteins [82]. NRF-1, NRF-2, SP1 and PGCla, Tfam, mTFBl and mTFB2 are the relevant transcription factors and cofactors
involved in mitochondrial biogenesis that have been identified to date [83]. In response to
biogenesis-inducing stimuli, transcription for these proteins changes before or coincident
with increases in the expression of their target genes [82]. The data presented here
showed that hyperoxia increased mRNA expression of PGC-la, NRF-1 and NRF-2 as
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well as Tfam expression concurrently in TG hearts. However, in the WT control group,
although there was an early increase in the mRNA expression of PGC-la, NRF-1 and
NRF-2, and this response did not persist with prolonged hyperoxia as in TG mice.
Because the promoter region of Tfam has consensus motifs recognized by NRF-1 and or
NRF-2 upstream of the transcription machinery [84], the decrease in NRF-1 and NRF-2
may explain the down regulation of Tfam transcripts in the WT hearts. Cooperation
among DNA-binding proteins and promoter diversity among nuclear genes for
mitochondria regulate biogenesis [85]. PGC-la has a major impact on the NRF system,
and transfection of PGC-la in muscle cells dramatically induces gene expression for
NRF-1, NRF-2, and Tfam. Furthermore, PGC-la physically interacts with NRF-1 and coactivates its transcription activity [11]. Because PGC-la promoters have multiple sites
for redox-sensitive transcription factors, e.g., CREB and API [86, 87], oxidant regulation
of PGC-1 a should co-activate NRF-1 and NRF-2 simultaneously, which are also
oxidant-sensitive transcription factors. Furthermore, mutations that affect PGC-la
expression lead to loss of heart mitochondria and down regulation of mitochondrial
enzymes [13]. Interestingly, PGC-la has been also shown to be induced in brown fat
cells on cold stimulation, suggesting that PGC-la strongly co-actives several nuclear
receptors (PPAR gamma, PPAR alpha, RAR and TR) that bind to mitochondrial
uncoupling protein-1(UCP-1) enhancer [12]. So PGC-la in cardiac cells regulates several
genes of the electron transport chain, mitochondrial biogenesis, and fatty acid 13oxidation. Effective cardioprotection would require not only cardiomyocyte survival but
also preservation of function. Acute activation of PI3-kinase or Akt is sufficient to inhibit
cardimyocyte apoptosis [88], but more importantly, acute activation of Akt also preserves
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function in surviving cardiomyocytes [89]. In cardiomyocytes, IGF-1 activates PI 3kinase /Akt signaling pathway, which appears largely necessary to reduce hypoxiainduced apoptosis in cardiomyocytes in vitro [88]. In this study, acute activation of Akt
(at 6 hours) by hyperoxia in both WT and TG hearts provides direct evidence that the PI
3-k/Akt pathway was a protective response induced by high oxygen exposure (100% O2 ).
The exact mechanism that activates PI3k/Akt pathway in hyperoxia is not yet delineated.
However, the increase in activity of EC-SOD may contribute to increased dismutation of
.0~2 to H2 O2 which could mediate the activation of the PI3k/Akt pathway [90]. Greater
Akt activation in EC-SOD TG mice than in WT mice after hyperoxia may indicate either
that Akt activation is stimulated by the production of more H2 O2 by extra EC-SOD
enzyme or that TG mice have less oxidative damage so the activation of the pro-survival
pathway is more evident.
The acute increase in Akt was coincident with an increase in PGC-la, and NRF-1
mRNA expression, suggesting that PGC-la and NRF-1 are activated by Akt in our mice
after hyperoxia. This stimulation of mitochondrial biogenesis markers confirms that Akt
has an important role in promoting cell survival. Besides its effect as a pro-survival
factor, Akt has also been found to restore cardiac function in normal and failing heart
most probably by increasing SERCA phosphorylation by Akt which enhances calcium
mobilization in the heart [91]. Additional molecular work will be needed to determine if
Akt activation by oxygen leads to phosphorylation and nuclear translocation of NRF-1
and PFC-la.
Akt also plays an important role in inhibiting apoptosis: adenoviral expression of
constitutively active mutants of either PI 3-k or Akt reduces hyperoxia-induced apoptosis
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in cardiomyocytes in vitro [88]. Multiple anti-apoptotic downstream effectors of Akt
have been identified. Phosphorylation of the pro-apoptotic Bel family protein, Bad, has
been reported to mediate anti-apoptotic signaling [33, 92]. Also phosphorylation of
caspase -9 by Akt inhibits its activity [93]. Phosphorylation of the Forkhead transcription
factors, F0X03a, by Akt induces nuclei exclusion and reduces transcription of specific
pro-apoptotic molecules [94]. In our study, a concomitant increase of p-Akt and pBad in
the TG hearts at base line in air-control group (~ 4-fold in pBad) substantiates the
Akt/Bad pathway activation in these TG mice and implies that they are better protected
from apoptotic cell death. Also in our study, increased phosphorylation of glycogen
synthase kinsae-3P (GSK-3p) in TG mice in the air control and after hyperoxia groups is
an indication that Akt/GSK signaling pathway is activated. Phosphorylation of GSK-3P
by Akt inactivates GSK-3P and leads to inhibition or delayed activation of the
mitochondrial permeability transition, a key regulator of apoptosis. Also, it is reported
that overexpression of catalytically active GSK-3P induces apoptosis, whereas expression
of a dominant-negative prevents apoptosis after inhibition of PI-3K [95].
Activation of the Akt signaling pathway by adrenomedullin (a potent vasoactive
peptide) protects against cardiomyocyte apoptosis induced by ischemia/reperfusion injury
through the Akt-GSK caspase signaling pathway [96]. It is also reported that increased
Akt activity inactivates GSK-3P and downregulates caspase 3- activity and decreases
apoptosis in cardiomyocytes. Other studies have shown drugs that inhibit GSK-3P are
cardioprotective [97, 98] and appear to mediate cardioprotection by phosphorylation of
GSK-3P [40]. These studies support our finding that increased phosphorylated GSK-3P in
EC-SOD mice hearts mediate cardioprotection.
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Negative regulation of Akt in the heart is important, because continuous
activation of Akt is sufficient to induce substantial cardiac hypertrophy [99, 100]. Akt is
inactivated either through inhibition by PTEN, which inhibits PI3-k /Akt signaling
pathway[101-103] or through dephosphorylation of Akt itself by phosphatase, PP2A
[104]. Such negative regulation might explain the decrease in the expression of Akt after
72 hours exposure to hyperoxia that we found in TG mice. This will require additional
work.
Because p38 is a stress kinase that is cell type and stimulus dependent, its
signaling has been shown to promote cell death in some cell lines, while in other cell
lines it enhance survival, cell growth and differentiation. In the heart, activation of p38 is
accompanied by cardiomyocyte hypertrophy. Also because p38 functions upstream and
downstream of caspases in apoptosis its activation can promote apoptosis [105, 106].
Activation of p38 in this study by hyperoxia was significantly increased in the WT mice
hearts after only 6 hours of exposure. While the MAPK p38 pathway did not change in
the TG mice after 6h of hyperoixa, it decreased afterwards. Decreases in p38 activation in
TG hearts after hyperoxia exposure indicates that p38 apoptotic pathway is not activated,
and these mice should be protected from apoptosis.
This study provides the first evidence that overexpression of extracellular
antioxidant enzyme EC-SOD protects an intracellular organelle, the mitochondria, from
oxidative stress. Also TG mice respond to oxidative stress induced by hyperoxia through
activation of the cell survival pathway mediated by PI3k/Akt signaling pathway.
Moreover, the important role of Akt in promoting cell survival appears to be mediated via
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activation of all or part of the mitochondrial biogenesis pathways and inhibition of proapoptotic pathways.

Part 2: Discussion for EC-SOD KO Mice Data
Mitochondrial DNA (mtDNA) deletions have been shown to increase with aging
and ischemia as a result of oxidative stress, and are suggested to contribute to myocardial
dysfunction [14,107]. In this study we demonstrated that hyperoxia induces
mitochondrial DNA deletion in KO mouse hearts. Accumulation of ROS during
hyperoxia exposure in these KO mice may be the direct cause of this mtDNA deletion.
The deleted part of the mitochondrial genome (3810 bp) constitutes about 23% of the
total mtDNA genome (16459 bp). Because the 3810 bp deleted portion of mitochondrial
genome includes codons for NADH dehydrogenase (ND1 and ND2), cytochrome c
oxidase (COX I), 16S rRNA and six tRNAs mitochondria carrying this deletion in
sufficient copy number will have changes in the OXPHOS system, which further
amplifies ROS formation and diminishes production, and may predispose to heart failure.
The high mortality rate (25%) among the EC-SOD KO mice after prolonged continuous
hyperoxia may be due to lung or cardiac damage or both, caused by excessive ROS
formation. Oxygen itself is implicated because the heart mitochondria manifested an
increased mtDNA deletion in cardiomyocytes (24%), especially in EC-SOD KO mice. In
otherwords, the absence of EC-SOD probably led to accumulation of overwhelming
levels of ROS (.O2 ’) after exposure to hyperoxia that influenced not only the extracellular
milieu but also the mitochondrial compartment, either directly or indirectly, causing
appreciable oxidative damage to mtDNA. Deletion of mtDNA had been found in tissues
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of coronary artery disease patients [108]. The increased oxidative stress in cardiovascular
disease especially from transient episodes of ischemia may be responsible for the
accumulation of mtDNA damage in these patients.
When mitochondrial gene transcription was measured using RT-PCR, we found
that the transcript for 12S rRNA in KO compared to the WT hearts was decreased at
baseline in air control mice. Thus, lack of EC-SOD not only affects the mitochondrial
compartment during hyperoxia but also under normal conditions. This decrease in 12S
rRNA in EC-SOD KO mice is most probably due to oxidative damage to mtDNA which
affects transcription of its genes. In contrast, expression of nuclear gene COX IV was
similar between the KO and WT mice at baseline. These findings confirm that the
mtDNA genome is more sensitive to oxidative damage than the nuclear genome in the
heart, especially in the absence of EC-SOD.
Expression of the mitochondria antioxidant SOD2 (MnSOD) was also affected
during hyperoxia. At baseline the expression was higher in the KO mice compared to the
WT, perhaps to compensate for the absence of EC-SOD. However, SOD2 expression
decreased dramatically (~ 4.5 fold) after a 6 hour exposure to hyperoxia in both the WT
and KO mice. The exact mechanism responsible for this finding is not yet identified.
However, this phenomenon might be due to the increased CpG islands in the promoter
region of MnSOD and the susceptibility of these islands to oxidative stress induced
methylation, thus silencing of the gene. The CpG is a C+G rich area span >3.5 Kb near
the 5' edge of the SOD2 promoter region and extends into intron 2. Increased cytosine
methylation in this area induces epigenetic silencing of MnSOD gene expression. This
mutation has been found in many tumor cell lines, e.g myeloma cell line KAS 6/1 [109].
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Increased ROS formation in malignant cells or in hyperoxia exposure may lead to this
methylation. Enforced expression of SOD2 in many transformed cell has been associated
with suppression of the malignant phenotype of the transformed cells, suggesting that
SOD2 is also a tumor suppressor gene via protection of the mitochondrial compartment
[110].
In this study we also showed that nuclear respiratory factors, NRF-1 and NRF-2,
which regulate mitochondrial biogenesis, are stimulated early by hyperoxia in KO mouse
hearts but not the WT. The cardiac mRNA expression of NRF-1 and NRF-2 in WT mice
was inversely related to prolonged exposure to hyperoxia compared with that in the ECSOD KO mouse hearts. Excessive ROS production in KO mice may be the signal to
increase expression of these nuclear respiratory factors. Unexpectedly, the increase in
mRNA of NRF-1 and NRF-2 in KO mice after 6 hours exposure to hyperoxia was not
associated with an increase in PGC-la protein expression, a known nuclear receptor and
co-activator of NRF-1 [111]. Moreover, in addition to the decrease in PGC-1, the
decrease in activated Akt, phosphorylated Bad and GSK proteins in the KO mice after
hyperoxia imply that early expression of NRF-1 and NRF-2 in the KO mice was not due
to activation of Akt and not associated with PGC-1. The decrease in Tfam expression
after exposure for 6 hours in both KO and WT may be also due to methyaltion of the
NRF-1 binding site of the Tfam promoter, therefore suppressing Tfam expression and
decreasing mitochondrial biogenesis, as was reported by another group [112].
There are many links between Ca2+ and respiratory gene expression mediated by
Ca2+ -dependent regulatory enzymes, Ca2+/calmodulin-dependent protein kinase
(CAMK) and protein kinase C (PKC). It was reported that calcium ionophores lead to
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increase of cytochrome c gene expression through a Ca2+ -sensitive and PKC-dependent
pathway [113]. Activation of CAMKIV due to changes in intracellular Ca2+ [16] and
activation of AMP kinases due to change in ATP/AMP ratio [114] can lead to an increase
in mitochondrial abundance. Our data on CAMKIV protein showed no significant change
in the expression in the KO or in the WT mice before or after exposure to hyperoxia,
which disqualifies the involvement of this pathway in activation of NRF-1 and NRF-2 in
this study.
The mitogen-activated protein kinase p38 is activated by cellular stressors in the
heart, including ischemia, hypoxia, and hypertrophic growth stimuli. The role of p38 MAPK in hyperoxia is not yet well understood and its role in myocardial ischemiareperfusion injury is controversial. Several lines of evidence suggest that the activation of
p38-MAPK/MAPKMAPK2/Hsp-27 axis contributes to ischemic preconditioning.
However, others have concluded that p38-MAPK inactivation might be cardioprotective
[115]. The different results might be due to the existence of two p38-MAPK isoforms (a
and (3) in the heart: while p38a transmits pro-apoptotic signals, p38(3 triggers a
hypertrophic response and promotes survival [116]. Our findings showed that p38 was
activated in KO mice after hyperoxia, which is consistent with the activation of NRF-1
and NRF-2. Activation of the nuclear respiratory factors here may suggest that the p38[3
is activated and this stimulated the pro-survival pathway. P38 was also activated in WT
mice after 6 hours exposure to hyperoxia but had decreased significantly by 72 hours. In
the heart, activation of p38 had been implicated in increased mitochondrial biogenesis
and energy levels in the cell through phosphorylation of peroxisome proliferativeactivated receptor alpha (PPARa) and its co-activator PGC-la [117]. The p38 isoforms
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need to be further defined in these KO and WT mouse hearts in order to discern the effect
of p38 on cell survival during hyperoxia.
The decrease of p-Bad and pGSK-3p expression after hyperoxia was more
prominent in the EC-SOD KO mice, consistent with decreased activation of Akt.
However, Akt was activated in the WT after 6 hours and was accompanied by
phosphorylation of BAD and no significant change in GSK-3J3. The responses to
hyperoxia in these two groups were different, as was the subsequent activation of cell
signaling pathways.
Our results indicate that EC-SOD KO mice are more susceptible to oxidative
mtDNA damage and mtDNA deletion than the WT control. In the absence of EC-SOD,
the activation of mitochondrial biogenesis in response to hyperoxia most probably
happens not through Akt, but may involve the activation of p38 MAPK. However, the
exact outline of the p38 activation pathway can not yet be drawn, but there may be
excessive oxidative stress which leads to decreased mitochondrial energy production.
This could decrease the ATP/AMP ratio and thereby stimulate cAMP, which would also
activate p38. This possibility will require further study. Also the decreased expression of
p-Bad and p-GSK-3(3 in KO mice after hyperoxia may suggest that the hearts of these
mice are more likely to undergo apoptosis, which needs to be evaluated specifically,
using cell death analysis in a future study.
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Part 3: General Discussion, Conclusions and Further Directions
This study has four main new findings. First, EC-SOD TG mice have a higher
tolerance to hyperoxia exposure than KO mice. Oxygen toxicity was manifest as
increased respiratory distress and an increased mortality rate in the KO mice. Second,
EC-SOD KO mice were more sensitive than TG mice to cardiac oxidative damage which
appeared as an increase in the extent of mtDNA deletions (23%) vs (3.4%). Third,
transcription of mitochondrial and nuclear genes decreased after exposure to hyperoxia in
KO mice in the some genes (12S rRNA, COX IV, SOD2, PGC-1, and Tfam) in contrast
to TG mice where the transcription increased after hyperoxia exposure. Fourth, there
were basal differences in cardiac mitochondrial gene expression in the genetically altered
EC-SOD mouse strains.
The absence of the EC-SOD enzyme in KO mice may increase formation of
reactive oxygen species (ROS) such as superoxide anion, hydroxyl radical and
peroxynitrite. ROS oxidatively damages mtDNA, and also affects mitochondrial and
nuclear mRNA expression. Because ROS are produced locally in the mitochondria by
leakage from electron transport and because mtDNA repair mechanisms are less efficient
than nuclear DNA repair mechanisms, a significant deletion or mutation in mtDNA can
affect mitochondrial respiration, and ATP production rates. This would decrease
cardiomyocyte function, which may lead to cardiac failure. A number of recent clinical
studies have reported reduced levels of human extracellular superoxide dismutase in
patients with cellular artery disease and myocardial infarction [118-120]. In Denmark, 23% of the population carries a mutation in the EC-SOD gene (R213G) which results in
increased plasma concentration of EC-SOD enzyme and reduced arterial wall EC-SOD
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concentration, and is associated with elevate risk for ischemic heart disease. [58].
Moreover, experience with EC-SOD gene therapy has been reported to protect the
myocardium against experimental episodes of ischemia/reperfusion injury [121,122].
Mitochondrial biogenesis markers NRF-1, NRF-2, Tfam, and PGC-la were upregulated in TG mice after short term exposure to hyperoxia. In KO mice, the NRF-1 and
NRF-2 increased after short term exposure to hyperoxia but Tfam and PGC-1 expression
increased after long term exposure to hyperoxia. The upstream signal for activation of
mitochondrial biogenesis most probably was through Akt activation in TG mice but this
could not be supported in the KO mice. Akt was not activated in the KO but the
stimulation of the nuclear respiratory factors was, and possibly through activation of p38.
Because we did not study p38 isoforms, it is not known for sure that activation of p38
found in the heart was either the signal for survival (p38 P) or apoptosis (p38a).
However, a decrease in pBad expression and pGSK-3p in KO mice after hyperoxia
exposure suggests that these mice are more likely to have cardiomyocyte apoptosis
during oxidative stress.
Conclusions: Systemic hyperoxia consistently increases mitochondrial biogenesis
markers in the mouse heart, most prominently in EC-SOD TG mice, and co-incidentally
with increases in Akt, CAMK, p-Bad and p-GSK-3p. This suggests that extracellular
ROS, most likely hydrogen peroxide, activate mitochondrial biogenesis and the pro
survival pathway in TG mice. On the other hand, the presence of the transgene may allow
augmentation of nitric oxide (NO bioactivity) to stimulate biogenesis, e.g. through cyclic
GMP-mediated effects. This possibility was not explored. Also, hyperoxia decreased the
activation of Tfam and PGC-la transcription after 6 hours and increased it again after 72
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hours in KO mice. This was associated with decreased expression of Akt, CAMK, p-Bad
and p-GSK-3|3 and an increase in p38, indicating that either hyperoxia activated
mitochondrial biogenesis and pro-survival pathways through p38 or that hyperoxia
produced more oxidative damage to the mitochondria in the KO. In the latter case, the
increase in p38 may be a signal for activation of apoptotic pathways. These unexpected
findings in KO mice need further exploration in the future.

Further Directions:
The following studies should help further elucidate the mechanisms by which EC-SOD
protects the heart from hyperoxia and other types of extracellular oxidative stress.
1-Examine the TG and KO mouse heart tissues for evidence of apoptosis by TUNEL and
DNA laddering.
2- Measure caspase -3 and cytochrome c activity to assess mitochondrial initiation of
apoptosis.
3- Measure the expression of p38 isoforms in the hearts in the TG and KO mice to
evaluate the possible protective activation of this signaling pathway during hyperoxia
stress.
4- Measure ANF as a marker for cardiac hypertrophy and functional impairment.
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